AROMATASE INHIBITORS-TYPES AND ADVANTAGES by C., BENEDICT PAUL & C., SUDANDIRADOSS
 
AROMATASE INHIBITORS-TYPES AND ADVANTAGES 
Erratum 
 
BENEDICT PAUL C.1, SUDANDIRADOSS C.2* 
1Department of Biotechnology, Sri Ramachandra University, Chennai 600116, India, 2Department of Biotechnology, School of Biosciences 




The role of aromatase inhibitors in the management of breast cancer has been promising as it markedly suppresses the production of estrogen. The 
inhibitors are very effective in postmenopausal women and used as the first-line therapy for hormone-sensitive breast cancer. The third-generation 
aromatase inhibitors are advantageous, having less adverse effects over other breast cancer drugs and they have also been recommended for use 
with tamoxifen. The aromatase inhibitors are of two different types; steroidal and nonsteroidal. Steroidal inhibitors are mechanism-based inhibitors 
that mimic the natural substrate and are irreversible, unlike non-steroidal inhibitors, which are reversible. The expression of aromatase occurs in a 
tissue-specific manner with a set of distinctive transcription factors. In tumorous breast tissue, the enzyme is overexpressed with the help of four 
different promoters, I.3, I.4, I.7 and II and in turn, the growth stimulatory effects of estrogen is magnified to very high levels. Aromatase inhibition 
approach is considered as the gold standard and hence, in this review, we have discussed different types of aromatase inhibitors with their 
advantages. 
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